Sumeyye Samur

Health Economist

Sumeyye joined the Institute for Clinical and Economic Review (ICER) as a health economist in July 2018. In her role, she develops models that look at the clinical and economic evaluations of the drug and nondrug treatments and interventions in the United States. Also, she is responsible for overseeing the models developed by the external collaborators of ICER. Before coming to ICER, Sumeyye was a post-doc at Harvard Medical School and a research fellow at Massachusetts General Hospital (MGH), Institute for Technology Assessment. There, she mainly worked in liver diseases including hepatitis-C virus, non-alcoholic fatty liver, primary biliary cholangitis and liver transplant. During her research, she has been a co-investigator to a project awarded by AASLD Innovation Fund from the American Association for the Study of Liver Diseases. She has authored/co-authored over 30 publications including papers, proceedings, and abstracts. Sumeyye's research has been featured in the media more than 20 times,  including in press releases and interviews. In June 2018, The Massachusetts State House of Representatives honored Sumeyye for her outstanding contribution to the study of health care and the future of medicine in the US. Sumeyye holds a BS degree in Computer Engineering from Fatih University, Turkey. She received her MS degree in Computer Engineering and a PhD degree in Industrial Engineering from Marmara University, Turkey.